Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics
scientific article
Author/s
author:
Zachary A. Cooper,
Keith Flaherty,
David E. Fisher,
Jennifer Wargo,
Roberto A Salas Fragomeni,
Dennie T Frederick
Wikidata